- Report
- October 2026
- 364 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 372 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 467 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 182 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 279 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 284 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 279 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 273 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 177 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 486 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 388 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 387 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 380 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 568 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 281 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 395 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 281 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 469 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 287 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 359 Pages
Global
From €5388EUR$5,850USD£4,554GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more